However, CEA is not considered effective as a marker for cancer screening, because CEA levels increase with age and are elevated in many nonneoplastic conditions including smoking, inflammatory bowel disease, and chronic hepatitis [13]–[15]. The gene discussed is CEACAM5; the disease is chronic hepatitis.